ConductScience.org, home

Paper17510371

Optimized preservation of CNS morphology for the identification of glycogen in the Pompe mouse model.

Taksir TV and 5 others. J Histochem Cytochem, 2007. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Optimized preservation of CNS morphology for the identification of glycogen in the Pompe mouse model. Papers, record 17510371. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17510371

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Optimized preservation of CNS morphology for the identification of glycogen in the Pompe mouse model.
PubMed
Journal
J Histochem Cytochem
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
0.44
iCite
Revised in PubMed
2013-11-21
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Taksir TVTatyana V
2Griffiths DDenise
3Johnson JJennifer
4Ryan SSusan
5Shihabuddin LSLamya S
6Thurberg BLBeth L

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BrainMajor topic
GlycogenMajor topic
Glycogen Storage Disease Type IIMajor topic
Tissue FixationMajor topic
Animals
Buffers
Cerebellum
Disease Models, Animal
Fixatives
Formaldehyde
Mice
Mice, Inbred C57BL
Mice, Knockout
Paraffin Embedding
Periodic Acid

Source PubMed

Download CSV of topics

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
42130276Placental Lesions in CD-1 Mouse Placenta Following Gestational Exposure to Perfluorooctanoic Acid (PFOA) or Hexafluoropropylene Oxide Dimer Acid (HFPO-DA or GenX).Toxicol Pathol2026https://conductscience.org/library/papers/42130276PubMed
42100166Mosaic pathogenic PRKAG2 variant and pathologic diagnosis of glycogen storage disease in an infant with negative whole-genome sequencing.JHLT Open2026https://conductscience.org/library/papers/42100166PubMed
40893165Novel transferrin receptor-mediated enzyme replacement therapy efficiently treats myogenic and neurogenic aspects of Pompe disease in mice.Mol Ther Methods Clin Dev2025https://conductscience.org/library/papers/40893165PubMed
39604266A novel CD71 Centyrin:Gys1 siRNA conjugate reduces glycogen synthesis and glycogen levels in a mouse model of Pompe disease.Mol Ther2025https://conductscience.org/library/papers/39604266PubMed
35715554Imaging peripheral nerve micro-anatomy with MUSE, 2D and 3D approaches.Sci Rep2022https://conductscience.org/library/papers/35715554PubMed
32637453A Novel Gene Therapy Approach for GSD III Using an AAV Vector Encoding a Bacterial Glycogen Debranching Enzyme.Mol Ther Methods Clin Dev2020https://conductscience.org/library/papers/32637453PubMed
31660421AAV Gene Therapy Utilizing Glycosylation-Independent Lysosomal Targeting Tagged GAA in the Hypoglossal Motor System of Pompe Mice.Mol Ther Methods Clin Dev2019https://conductscience.org/library/papers/31660421PubMed
31392201An emerging phenotype of central nervous system involvement in Pompe disease: from bench to bedside and beyond.Ann Transl Med2019https://conductscience.org/library/papers/31392201PubMed
30809555Intravenous Injection of an AAV-PHP.B Vector Encoding Human Acid α-Glucosidase Rescues Both Muscle and CNS Defects in Murine Pompe Disease.Mol Ther Methods Clin Dev2019https://conductscience.org/library/papers/30809555PubMed
28895054A Neuron-Specific Gene Therapy Relieves Motor Deficits in Pompe Disease Mice.Mol Neurobiol2018https://conductscience.org/library/papers/28895054PubMed
27491085Loss of vhl in the zebrafish pronephros recapitulates early stages of human clear cell renal cell carcinoma.Dis Model Mech2016https://conductscience.org/library/papers/27491085PubMed
26921786Neuropathology in respiratory-related motoneurons in young Pompe (Gaa(-/-)) mice.Respir Physiol Neurobiol2016https://conductscience.org/library/papers/26921786PubMed
24448824Adjunctive β2-agonist treatment reduces glycogen independently of receptor-mediated acid α-glucosidase uptake in the limb muscles of mice with Pompe disease.FASEB J2014https://conductscience.org/library/papers/24448824PubMed
23609349The brain in late-onset glycogenosis II: a structural and functional MRI study.J Inherit Metab Dis2013https://conductscience.org/library/papers/23609349PubMed
22993195Adjunctive β2-agonists reverse neuromuscular involvement in murine Pompe disease.FASEB J2013https://conductscience.org/library/papers/22993195PubMed
18648322Temporal neuropathologic and behavioral phenotype of 6neo/6neo Pompe disease mice.J Neuropathol Exp Neurol2008https://conductscience.org/library/papers/18648322PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17510371

GET https://conductscience.org/api/papers/v1/17510371/authors